A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

AstraZeneca and Moderna Are Neck and Neck in Race for Vaccine


The World Health Organization states that AstraZeneca’s COVID-19 vaccine is leading the pack, with Moderna’s version a close second. Developed at Britain’s Oxford University, the AstraZeneca vaccine is already undergoing human trials. The vaccine made by Moderna in Cambridge, Massachusetts, is currently in phase three clinical trials. The field is crowded with more than 200 possible vaccines; however, approximately 15 are considered the most viable. Experts hope that a safe and effective vaccine will debut by the end of the year.

Read more here.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy